Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging Treatment Options in Inflammatory Bowel Disease: Janus Kinases, Stem Cells, and More
Benjamin Misselwitz, Pascal Juillerat, Michael Christian Sulz, et al.
Digestion (2020) Vol. 101, Iss. Suppl. 1, pp. 69-82
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Role of the IL23/IL17 Pathway in Crohn’s Disease
H Schmitt, Markus F. Neurath, Raja Atreya
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 143
IBD disease-modifying therapies: insights from emerging therapeutics
Niranjan G. Kotla, Yury Rochev
Trends in Molecular Medicine (2023) Vol. 29, Iss. 3, pp. 241-253
Closed Access | Times Cited: 65
A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis
Marek Vébr, Renata Pomahačová, Josef Sýkora, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3229-3229
Open Access | Times Cited: 25
Biosimilars versus biological therapy in inflammatory bowel disease: challenges and targeting strategies using drug delivery systems
Ahmed Aljabri, Ghareb M. Soliman, Yasmin N. Ramadan, et al.
Clinical and Experimental Medicine (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Translating Treg Therapy for Inflammatory Bowel Disease in Humanized Mice
Sushmita Negi, Sheetal Saini, Nikunj Tandel, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1847-1847
Open Access | Times Cited: 43
Crohn’s disease: a population-based study of surgery in the age of biological therapy
Christian Stöß, Maximilian Berlet, Stefan Reischl, et al.
International Journal of Colorectal Disease (2021) Vol. 36, Iss. 11, pp. 2419-2426
Open Access | Times Cited: 37
Evaluating Upadacitinib in the Treatment of Moderate-to-Severe Active Ulcerative Colitis: Design, Development, and Potential Position in Therapy
Maria Napolitano, Ferdinando D’Amico, Elisa Maria Ragaini, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 1897-1913
Open Access | Times Cited: 23
Upadacitinib as a Rescue Therapy in Acute Severe Ulcerative Colitis: A Case Report and Review of the Literature
Nargess Mahmoud Ali, Mohammad Shehab
American Journal of Case Reports (2023) Vol. 24
Open Access | Times Cited: 14
Muc2 mucin o-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway
Juan Wei, Chunyan Chen, Jing Feng, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
The role of sphingosine-1-phosphate in the gut mucosal microenvironment and inflammatory bowel diseases
Fei Zou, Su Wang, Mengmeng Xu, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 11
Bioactive lipids in inflammatory bowel diseases – From pathophysiological alterations to therapeutic opportunities
Mireille Alhouayek, Hafsa Ameraoui, Giulio G. Muccioli
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2020) Vol. 1866, Iss. 2, pp. 158854-158854
Closed Access | Times Cited: 30
Microbiota and Drug Response in Inflammatory Bowel Disease
Martina Franzin, Katja Stefančič, Marianna Lucafò, et al.
Pathogens (2021) Vol. 10, Iss. 2, pp. 211-211
Open Access | Times Cited: 26
Meta-analysis of gene expression disease signatures in colonic biopsy tissue from patients with ulcerative colitis
Bryan Linggi, Vipul Jairath, Guangyong Zou, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Role and Function of Mesenchymal Stem Cells on Fibroblast in Cutaneous Wound Healing
Kotaro Tanaka, Ryohei Ogino, Sho Yamakawa, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1391-1391
Open Access | Times Cited: 18
Childhood-onset inflammatory bowel disease and chronic non-bacterial osteomyelitis: A Swedish nationwide cohort study 2002–2022
Marianne Malmquist, S Voghera, Stefan Berg, et al.
Journal of Crohn s and Colitis (2025)
Closed Access
Fistula in Crohn’s disease: classification, pathogenesis, and treatment options
Kimia Basiji, Nesa Kazemifard, Maryam Farmani, et al.
Tissue Barriers (2025)
Closed Access
Ectoines as novel anti-inflammatory and tissue protective lead compounds with special focus on inflammatory bowel disease and lung inflammation
Lukas Bethlehem, Gerhild van Echten‐Deckert
Pharmacological Research (2020) Vol. 164, pp. 105389-105389
Closed Access | Times Cited: 24
Emerging therapeutic options in inflammatory bowel disease
Jesús K. Yamamoto‐Furusho, Norma N. Parra-Holguín
World Journal of Gastroenterology (2021) Vol. 27, Iss. 48, pp. 8242-8261
Open Access | Times Cited: 23
Drug Targeting of Inflammatory Bowel Diseases by Biomolecules
Joana C. Antunes, Catarina Leal Seabra, Joana Domingues, et al.
Nanomaterials (2021) Vol. 11, Iss. 8, pp. 2035-2035
Open Access | Times Cited: 21
Anti-inflammatory and Immunomodulatory Potency of Selenium-Enriched Probiotic Mutants in Mice with Induced Ulcerative Colitis
Abd El-Nasser A. Khattab, Ahmed M. Darwish, Sarah I. Othman, et al.
Biological Trace Element Research (2022) Vol. 201, Iss. 1, pp. 353-367
Open Access | Times Cited: 16
A Japanese Herbal Formula, Daikenchuto, Alleviates Experimental Colitis by Reshaping Microbial Profiles and Enhancing Group 3 Innate Lymphoid Cells
Zheng-Zheng Shi, Tadashi Takeuchi, Yumiko Nakanishi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Peach gum polysaccharides promotes epithelial proliferation to attenuate ulcerative colitis by PI3K/AKT pathway
Xiaobo Lin, Mengyao Lan, Cong Xu, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105662-105662
Open Access | Times Cited: 9
The Efficacy and Safety of Biologic Drugs in the Treatment of Moderate–Severe Crohn’s Disease: A Systematic Review
Ana Avedillo-Salas, Sara Corral-Cativiela, Ana Fanlo-Villacampa, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 11, pp. 1581-1581
Open Access | Times Cited: 9
Inflammatory Bowel Disease: From Conventional Immunosuppression to Biologic Therapy
Aleksandra Sokić-Milutinović, Tomica Milosavljević
Digestive Diseases (2023) Vol. 42, Iss. 4, pp. 325-335
Open Access | Times Cited: 9
Novel and emerging drugs for the treatment of Crohn’s disease: a review of phase II and III trials
Panu Wetwittayakhlang, Talat Bessissow, Péter L. Lakatos
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 1, pp. 19-34
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top